PATENT CLAIM ANALYSIS

Application Number: 16145345
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["546", "117000"]

Abstract:
The present invention provides compounds of Formula (I): wherein A, X and Y are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

Claim (Index 7):
A compound according to  claim 1 , wherein the compound is selected from any one of Examples 1 to 166 or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15756373', '15756367', '15756378', '16099010', '16067619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8243278977546685
- 35 USC 102 Novelty (BERT): 0.5796356523737538
- Combined Prediction Score: 0.799858673216577
- Mean Citation Score: 461.02643599999993
- Max Citation Score: 519.0335
- Similarity Product: 376.8350635051728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test